The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
Status:
Completed
Trial end date:
2018-06-05
Target enrollment:
Participant gender:
Summary
The investigators are studying whether MSM plus standard of care naproxen improves symptoms
of lower back pain compared to standard of care naproxen plus placebo. Subjects will be
randomized into 1 of 2 groups. Group 1 will take by mouth 6000 milligrams (mgs) of MSM plus
standard of care naproxen. Group 2 will take by mouth placebo capsules plus standard of care
naproxen. Subjects will be instructed to take their study pills for 12 weeks and record on a
study diary. They will then be followed up for one final visit 4 weeks later. RMDQ, PIQ-6,
pain level, comprehensive metabolic panel (CMP), complete blood count (CBC) will be assessed
at 4 week intervals for 12 weeks. Subjects' participation will last 16 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Mike O'Callaghan Federal Hospital Mike O'Callaghan Military Hospital